• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 50 of 100
BioGen Alzheimers
HealthBiogen’s Stock Is Soaring Because of Its Experimental Alzheimer’s Drug — But Some Are Urging Caution
By Sy MukherjeeJuly 6, 2018
Pfizer Raises Prices on Prescription Drugs Like Viagra and Chantix for the Second Time This Year
HealthPfizer Raises Prices on Prescription Drugs Like Viagra and Chantix for the Second Time This Year
By Brittany ShootJuly 2, 2018
Flu clinic
HealthThis New Single Dose Flu Drug Could Be Coming to the U.S. Before the Next Flu Season
By Sy MukherjeeJune 28, 2018
Sativex is a cannibanoid medecine manufactured by GW Pharmaceuticals. This mouth spray has just received approval to be launched on the French market, for limited use on patients suffering from multiple sclerosis.
HealthThis Company Made the First FDA Approved, Marijuana Based Drug. Here’s What It Wants to Do Next
By Sy MukherjeeJune 27, 2018
Alzheimers-dementia-brain-research
HealthThe AARP, UnitedHealth, and Quest Diagnostics Are Pouring $75 Million Into Fighting Alzheimer’s and Dementia
By Sy MukherjeeJune 26, 2018
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
HealthWhy Sarepta Stock Skyrocketed 40% Today
By Sy MukherjeeJune 19, 2018
Walgreens to Open Senior Care Centers With Humana
RetailWalgreens to Open Senior Care Centers With Humana
By Phil WahbaJune 19, 2018
Pedestrians walk by a CVS store on November 5, 2013 in San Francisco, California.
RetailCVS Launches Drug Delivery Nationwide as Amazon Threat Looms
By Phil WahbaJune 19, 2018
CHINA-ECONOMY-CREDI-LOANS-DEBT-GOVERNMENT
HealthA Cancer Blockbuster Gets Approved in China. Will the Floodgates Now Open?
By Clifton LeafJune 15, 2018
Alzheimers-dementia-brain-research
HealthEli Lilly, AstraZeneca’s Alzheimer’s Drug Flop Is the Latest Disappointment in a Frustrating Disease
By Sy MukherjeeJune 12, 2018
President Trump Signs "Right To Try" Act
HealthTrump Predicts ‘Massive Drops in Prices’ for Drugs. Here’s Why That Probably Won’t Happen
By Sy MukherjeeMay 30, 2018
Express Scripts To Buy Medco For $29.1 Billion To Gain Scale
HealthThe Drug Industry’s Middlemen Are in the Hot Seat
By Clifton LeafMay 21, 2018
Headache senior
HealthFDA Approves New Migraine Drug: What You Need to Know
By Don ReisingerMay 18, 2018
The FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising
HealthThe FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising
By David MeyerMay 18, 2018
The American Enterprise Institute photo of Scott Gottlieb
HealthThe FDA Is Naming and Shaming Companies Accused of Blocking Cheap Generic Drugs
By Sy MukherjeeMay 17, 2018
1...
  • 48
  • 49
  • 50
  • 51
  • 52
...100
Most Popular
Personal Finance
Social Security's 2032 deadline puts a 22% cut on the table — but Washington has way less room to negotiate than 1983placeholder alt text
By John W. Diamond and The ConversationJune 12, 2026
Success
CEO of $20 billion AI firm Perplexity says the secret to success is ‘sleeping with that fear’ that your competitor will steal your ideaplaceholder alt text
By Preston ForeJune 13, 2026
Energy
Iran proved it can close the Strait of Hormuz, but the U.S. is advertising very loudly that the world's top superpower can at least punch open a holeplaceholder alt text
By Jason MaJune 14, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.